PLANET LABS PBC (PL)

US72703X1063 - Common Stock

1.77  +0.03 (+1.72%)

Premarket: 1.8 +0.03 (+1.69%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to PL. PL was compared to 80 industry peers in the Professional Services industry. PL has a great financial health rating, but its profitability evaluates not so good. PL is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year PL has reported negative net income.
PL had a negative operating cash flow in the past year.
PL had negative earnings in each of the past 5 years.
PL had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

PL's Return On Assets of -20.02% is on the low side compared to the rest of the industry. PL is outperformed by 83.75% of its industry peers.
The Return On Equity of PL (-27.12%) is worse than 82.50% of its industry peers.
Industry RankSector Rank
ROA -20.02%
ROE -27.12%
ROIC N/A
ROA(3y)-19.41%
ROA(5y)-24.83%
ROE(3y)-25.47%
ROE(5y)-50.3%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

PL has a better Gross Margin (51.18%) than 63.75% of its industry peers.
PL's Gross Margin has improved in the last couple of years.
PL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y31.27%
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

PL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PL has been increased compared to 1 year ago.
PL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

PL has an Altman-Z score of -0.56. This is a bad value and indicates that PL is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.56, PL is not doing good in the industry: 82.50% of the companies in the same industry are doing better.
PL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.56
ROIC/WACCN/A
WACC9.26%

2.3 Liquidity

A Current Ratio of 2.71 indicates that PL has no problem at all paying its short term obligations.
PL has a Current ratio of 2.71. This is amongst the best in the industry. PL outperforms 86.25% of its industry peers.
A Quick Ratio of 2.71 indicates that PL has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 2.71, PL belongs to the best of the industry, outperforming 86.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.71
Quick Ratio 2.71

6

3. Growth

3.1 Past

PL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 49.18%, which is quite impressive.
PL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.39%.
PL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.93% yearly.
EPS 1Y (TTM)49.18%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q57.14%
Revenue 1Y (TTM)15.39%
Revenue growth 3Y24.93%
Revenue growth 5YN/A
Revenue growth Q2Q11.08%

3.2 Future

The Earnings Per Share is expected to grow by 24.51% on average over the next years. This is a very strong growth
PL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.95% yearly.
EPS Next Y28.4%
EPS Next 2Y27.87%
EPS Next 3Y24.51%
EPS Next 5YN/A
Revenue Next Year15.97%
Revenue Next 2Y17.66%
Revenue Next 3Y17.95%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PL. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PL's earnings are expected to grow with 24.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.87%
EPS Next 3Y24.51%

0

5. Dividend

5.1 Amount

PL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PLANET LABS PBC

NYSE:PL (4/23/2024, 7:19:27 PM)

Premarket: 1.8 +0.03 (+1.69%)

1.77

+0.03 (+1.72%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap514.40M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.02%
ROE -27.12%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 51.18%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.71
Quick Ratio 2.71
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)49.18%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y28.4%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)15.39%
Revenue growth 3Y24.93%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y